A Novel Screening Approach for the Dissection of Cellular Regulatory Networks of NF-κB Using Arrayed CRISPR gRNA

Patrick O'Shea1, Jan Wildenhain2, Mathew Leveridge1

  • 1Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Summary

We developed a scalable CRISPR/Cas9 screening workflow for functional genomics. This method enhances the identification of genes involved in TNF-α-mediated NF-κB signaling, outperforming previous RNAi techniques.

Related Concept Videos